• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data on how exposure to ADHD for a long time could affect the pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to consider the benefits of taking it against the potential dangers for the fetus. Physicians do not have the data needed to give clear guidelines, but they can provide information regarding the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy did not have a higher risk of fetal malformations or structural birth defects. The researchers used a large, population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy and those who had not. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure accurate classification of the cases and to reduce the possibility of bias.

However, the researchers' study was not without its flaws. The most important issue was that they were unable to distinguish the effects of the medication from the disorder at hand. This makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to medication use or if they were affected by co-morbidities. Additionally the study did not study long-term offspring outcomes.

The study showed that infants whose mother had taken ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU), compared to those whose mothers did not take any medication during pregnancy or had stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders, and the increased risk for admission did not appear to be influenced by which stimulant medication was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during early pregnancy may be offset by the higher benefit to both the mother and child of continued treatment for the woman's disorder. Physicians should discuss this with their patients and, where possible, assist them in developing strategies to improve their coping abilities that may minimize the negative impact of her condition on her daily life and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are frequently made without clear and reliable evidence. Instead, doctors have to take into account their own experience in conjunction with the experiences of other doctors and the research that has been conducted on the subject.

Particularly, the subject of potential risks for the baby can be tricky. A lot of studies on this subject are based on observational evidence rather than controlled research, and their findings are often contradictory. Additionally, the majority of studies limit their analysis to live births, which can undervalue the serious teratogenic effects that can cause abortion or termination of the pregnancy. The study presented in this journal club addresses these limitations by looking at data from both live and deceased births.

Conclusion A few studies have revealed a positive correlation between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. The majority of studies show an unintended, or slightly negative, impact. In each case it is imperative to conduct a thorough evaluation of the benefits and risks should be conducted.

For women suffering from ADHD, the decision to stop medication is difficult if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of isolation. Furthermore, a loss of medication can affect the ability to perform work-related tasks and safely drive which are essential aspects of daily life for many people with ADHD.

She suggests women who are uncertain about whether or not to stop taking medication because of their pregnancy consider informing family members, friends and colleagues about the condition, its effects on daily functioning, and on the advantages of staying on the current treatment regimen. It can also aid in ensuring that the woman feels supported as she struggles with her decision. It is also worth noting that certain drugs can a general practitioner prescribe adhd medication pass through the placenta so if a woman decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the drug can be passed on to the baby.

Birth Defects and Risk of

As the use and abuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD) increases the concern over the potential adverse effects of the drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. With two massive data sets researchers were able analyze more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists did find that first-trimester exposure to ADHD medications was linked to an increase in the risk of certain heart defects, such as ventriculoseptal defect (VSD).

The researchers behind the study found no association between early use of medication and congenital abnormalities like facial clefting, or club foot. The results are in line with previous studies which showed a small, but significant increase in cardiac malformations for women who began taking best adhd medication for women medication before pregnancy. This risk increased in the latter half of pregnancy, when many women begin to discontinue their medication.

Women who took ADHD medication in the first trimester were more likely need a caesarean and also have a low Apgar after birth and have a baby that needed help breathing when they were born. However the authors of the study were unable to eliminate bias due to selection by restricting the study to women who did not have any other medical conditions that could be a contributing factor to these findings.

Researchers hope that their research will inform physicians when they meet pregnant women. They recommend that, while the discussion of risks and benefits is important however, the decision to stop or keep treatment should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors warn that, even though stopping the medication is an option to think about, it isn't advised due to the high rate depression and mental health issues in women who are expecting or recently gave birth. Further, the research suggests that women who choose to stop their medications are more likely to experience a difficult time getting used to life without them following the baby's arrival.

Nursing

The responsibilities of being a new mom can be overwhelming. Women who suffer from ADHD who must work through their symptoms while attending physician appointments as well as preparing for the arrival of their child and getting adhd medication uk used to new routines at home may face a lot of challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant drugs are absorbed through breast milk in small amounts, so the risk for nursing infant is very low. The amount of exposure to medications will vary based on the dosage and frequency of administration as well as the time of day. Additionally, different medications enter the baby’s system via the gastrointestinal tract, or through breast milk. The effect on the health of a newborn isn't fully known.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the absence of research. This is a difficult decision for the patient, who can prescribe medication for adhd (visit Tyc here >>) must weigh the benefits of continuing her medication with the potential risks to the fetus. Until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are planning or taking to take medication during the perinatal period.

Numerous studies have proven that women can continue to take their ADHD medication without risk during pregnancy and while breast-feeding. This has led to many patients are choosing to do so and in consultation with their physician, they have found that the benefits of keeping their current medication exceed any risk.

Women with ADHD who are planning to breastfeed should seek advice from a specialist psychiatrist before becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder and learn about treatment options and strengthen existing coping strategies. This should involve a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Pregnancy counselling should include the discussion of a plan for management for both mother and child, monitoring for signs of deterioration, and the need for adjustments to the medication regimen.